Evidence map›Paper›PMID 37254549›Full record

ArticleCurrent computer-aided drug design2024

Synthesis, Docking Study of Some Novel Chromeno[4',3'-b]Pyrano [6,5-d]Pyrimidine Derivatives Against COVID-19 Main Protease (Mpro) (6LU7, 6M03).

Radineh Motamedi, Safieh Soufian, Zahra Rostami Ghalhar, Mahdiyeh Jalali, Hooman Rahimi

Abstract read
PubMed Publisher
In one paragraph

Article in Current computer-aided drug design, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Radineh MotamediDepartment of Chemistry, Payame Noor University, Tehran, Iran.
Safieh SoufianDepartment of Biology, Payame Noor University, Tehran, Iran.
Zahra Rostami GhalharDepartment of Chemistry, Payame Noor University, Tehran, Iran.
Mahdiyeh JalaliDepartment of Chemistry, Payame Noor University, Tehran, Iran.
Hooman RahimiDepartment of Chemistry, Payame Noor University, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsIn this work, some new chromeno[4',3'-b]pyrano[6,5-d]pyrimidines,3-amino and 3-methyl-5-aryl-4-imino-5(H)-chromeno[4',3'-b]pyrano[6,5-d]pyrimidine-6-ones derivatives were synthesized.

backgroundChromenopyrimidines have attracted significant attention recently because of their activities, such as antiviral and cytotoxic activity.

objectiveAll synthesized compounds were characterized using IR,

methodsMolecular docking studies were carried out to determine the inhibitory action of studied ligands against the Main Protease (6LU7, 6m03) of coronavirus (COVID-19). Moreover, the Lipinski Rule parameters were calculated for the synthesized compounds.

resultsThe result of the docking studies showed a significant inhibitory action against the Main protease (M

conclusionIt may conclude that some ligands were likely to be considered lead-like against the main protease of SARS-CoV-2.

Indexed as

Antiviral AgentsCoronavirus 3C ProteasesMolecular Docking SimulationPyrimidinesSARS-CoV-2COVID-19 Drug TreatmentHumansProtease InhibitorsAntiviral AgentsCoronavirus 3C ProteasesProtease InhibitorsPyrimidines3'-b]pyrano[64-Hydroxy coumarin5-d]pyrimidinesChromeno[4'COVID-19.main proteasemolecular modelingSARSCoV- 2

Identifiers

PMID37254549

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.